Sequella Revenue

Biotechnology Research • Rockville, Maryland, United States • 1-10 Employees

Sequella revenue & valuation

Annual revenue	$8,000,000
Revenue per employee	$1,334,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$25,600,000
Total funding	$940,900

Key Contacts at Sequella

Carol Nacy

Ceo

Lisa Beth Ferstenberg

Medical Director

Company overview

Headquarters	9610 Medical Center Drive, Suite 200, Rockville, Maryland 20850, US
Phone number	+13017627776
Website	sequella.com
NAICS	541714
SIC	283
Founded	1997
Employees	1-10
Socials

Sequella Email Formats

Sequella uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@sequella.com), used 100% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@sequella.com	100%

About Sequella

Sequella is a private, clinical-stage pharmaceutical company that addresses the challenge of antibiotic-resistant bacterial diseases by discovery, development, and commercialization of first-in-class antibiotics with novel mechanisms of action. Our lead drug candidate identified from our current >150,000 proprietary compound library, SQ109, is in Phase 2 clinical trials for treatment of both tuberculosis (TB) and gastritis (Helicobacter pylori infections), diseases complicated by growing resistance to existing drugs. In 2013, we acquired a new clinical-stage (Phase 2) oxazolidinone, sutezolid, for treatment of TB and other resistant bacterial diseases. We also have a vigorous research program to develop novel antibiotics that target the enzyme translocase-1, an essential enzyme in all bacteria. Our product portfolio addresses global health threats with significant market opportunity in disease areas of known or suspected infectious etiology: * TB (Mycobacterium tuberculosis) * Duodenal ulcers (Helicobacter pylori) * Gastric carcinomas (Helicobacter pylori) * CDI (Clostridium difficile) * Crohn’s Disease (Mycobacterium avium paratuberculosis) * Chagas Disease (Trypanosoma cruzi)

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Director

Senior

Employees by Department

Sequella has 2 employees across 2 departments.

Departments

Number of employees

Funding Data

Explore Sequella's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2016-10-21	1	$940,900

Funding Insights

$940,900

Total funding amount

$940,900

Most recent funding amount

Number of funding rounds

Sequella Tech Stack

Discover the technologies and tools that power Sequella's digital infrastructure, from frameworks to analytics platforms.

SWFObject

Miscellaneous

DreamWeaver

Editors

Adobe Flash

Programming languages

Nginx

Reverse proxies

HSTS

Security

Sectigo

SSL/TLS certificate authorities

Google Analytics

Analytics

OpenResty

Web servers

Frequently asked questions

Sequella is located in Rockville, Maryland, US.

You can reach Sequella at +13017627776.

Sequella generates an estimated annual revenue of $8,000,000. This revenue figure reflects the company's market position and business performance in its industry.

Sequella has an estimated valuation of $25,600,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Sequella was founded in 1997, making it 29 years old. The company has established itself as a significant player in its industry over this time.

Sequella has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Sequella has raised a total of $940,900 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Sequella

Carol Nacy

Ceo

Lisa Beth Ferstenberg

Medical Director

4.8

40,000 users